Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
about
Behavioral and psychological symptoms of dementiaPredicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomographyGliomatosis cerebri presenting as rapidly progressive dementia and parkinsonism in an elderly woman: a case reportRole of imaging techniques in the diagnosis of dementiaThe synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementiaMeta-analysis of early nonmotor features and risk factors for Parkinson diseaseC9orf72 repeat expansions are a rare genetic cause of parkinsonismMontreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementiasMini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populationsDopamine transporter imaging for the diagnosis of dementia with Lewy bodiesStatin withdrawal in people with dementiaRegional Cerebral Blood Flow Single Photon Emission Computed Tomography for detection of Frontotemporal dementia in people with suspected dementiaInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care settingMini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care settingMini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care settingMini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community settingInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settingsMini-Mental State Examination (MMSE) for the detection of Alzheimer’s dementia and other dementias in asymptomatic and previously clinically unevaluated people aged over 65 years in community and primary care populations11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) settingAD-8 for diagnosis of dementia across a variety of healthcare settingsInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populationsCSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a general practice (primary care) settingIQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care settingNeuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studiesCholinesterase inhibitors for mild cognitive impairmentIQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a community setting11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community settingAPOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care settingPlasma and Cerebrospinal fluid (CSF) Abeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care settingCholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's diseaseDopamine transporter imaging for the diagnosis of dementia with Lewy bodiesMini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a community settingThe role of MRI in the early diagnosis of Alzheimer’s disease or other dementias in persons with mild cognitive impairment (MCI)Cholinesterase inhibitors for mild cognitive impairmentAntidepressants for agitation and psychosis in dementiaCholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease
P2860
Q21129432-64E0A0F8-86DC-4327-A67B-5D289F4883A0Q21146623-0B417CB2-1EC2-4AE9-8920-434117A6D512Q21202113-E4017384-7EC9-41A8-B3A1-995030F48EC0Q22241579-B290A227-18E9-45B1-9DB7-1E9D52C18695Q22252705-F86AFE3B-F4AD-45AB-A6FA-45AEC8818B82Q22252935-C801D982-061E-48B9-B284-5C00080A21EBQ23936600-9876404A-E46E-489E-B3B9-D4A3B3E1415BQ24186280-20D5BF83-F9D7-4D81-A7AF-24411B51DDE2Q24186302-AF2C15D4-BCD2-408B-BCBF-FD8E906117FDQ24186395-E22DA2EB-DEBB-446D-895A-8F7BFFE6A1CAQ24186720-82ACF8E6-739B-496A-BE99-2BC78B462B2CQ24186916-F0A270AD-25DA-472A-B04E-E88148853CC2Q24187059-B80BCF7D-CF07-4ADA-A4F8-20561C27244BQ24187527-3B37A4DC-226A-4762-A508-92A9A376304CQ24187538-A8DAA981-37B2-494D-A6D6-441D829AA82BQ24187908-16CF7486-CF6C-4CEC-9DB1-FEE73B5E122FQ24193211-7904B0DA-31A4-42A1-B15C-D0E9737FC0AFQ24194186-968AC9CE-C9A6-4C12-B1B6-D199F10A95CEQ24194742-C4A0AA02-1A1D-4A90-BD09-DA89434A29F0Q24194747-C287B25B-0545-4724-9BBD-B7EA69AA1B65Q24194796-6941845B-D5BD-413C-BA18-02CCEF78A0ADQ24194962-3F0BBB03-0381-4930-8C00-B8FC5F9A955BQ24197654-20B63822-E0FB-4932-858A-50678968459CQ24197659-CB0C3F84-1F00-4358-8B9B-CCA444007F3BQ24197665-599D8F3C-B12A-46D7-97FD-C1200B3E4C21Q24197672-27B941BF-2760-4EF8-83AA-35EF96AABDD1Q24200257-F9BA89DD-2F18-4A65-AC0D-0BBB50099A95Q24200430-3DBD4B26-C9B8-4E67-9B97-39D72AD28FCEQ24200918-E5168095-D833-497D-8401-3A5A56A801BCQ24201039-75AEFAFC-CF4A-4F98-8930-C7E97588BB64Q24201260-9B2CD0FA-8830-45CA-87B9-64170CD3531DQ24201271-3B0F01E8-11F9-4A15-A13D-2B286B4EF736Q24201276-8EB7EA02-341D-42DD-ADBA-D17958D329F1Q24201307-7D59221C-F954-4F5B-97F0-914541C59C36Q24201437-EBD09D3B-00E1-41EF-9E6D-D322F68666B7Q24202610-7F8CD00F-51F8-4E7B-8DB1-7155848E33EDQ24203748-9FF2DC90-217D-4776-99BC-BFC49ED4A61FQ24234894-CC25028B-367B-40DF-BF2F-4F9922675469Q24236550-820667EB-9D8C-4F10-A344-7F698040FD0BQ24245967-1FCA3C78-A8C2-441A-8754-01830EA3D618
P2860
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
@ast
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
@en
type
label
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
@ast
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
@en
prefLabel
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
@ast
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
@en
P2093
P50
P3181
P1433
P1476
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
@en
P2093
Consortium on DLB
E B Mukaetova-Ladinska
P304
P3181
P356
10.1212/01.WNL.0000187889.17253.B1
P407
P50
P577
2005-10-19T00:00:00Z